Reduction Of The Electrocardiographic Qt Interval

Abstract

The present invention relates to the use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing the OTc interval and the use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing the risk of sudden death or 'dead in bed' syndrome; particularly in patients suffering from IDDM.


Claims
Download PDF
Document Preview
Document History
  • Publication: May 8, 2007
  • Application: Aug 7, 2003
    US US 38030103 A
  • Priority: Sep 12, 2001
    GB GB 0104095 W
  • Priority: Sep 12, 2000
    GB GB 0022342 A

Download Citation


Sign in to the Lens

Feedback